Syngen Biotech Co.,Ltd. (TPEX:8279)

Syngen Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,131	2,014	1,837	1,931	1,471	1,311
Revenue Growth (YoY)	6.55%	9.60%	-4.84%	31.22%	12.19%	1.09%
Cost of Revenue	1,372	1,290	1,193	1,242	942.93	816.02
Gross Profit	759.86	723.94	643.92	688.15	528.34	495.41
Selling, General & Admin	350.76	354.38	302.88	262.63	197.02	194.51
Research & Development	60.16	59.34	46.76	45.32	49.52	43.42
Operating Expenses	403.03	420.64	341.06	325.78	246.86	236.15
Operating Income	356.82	303.3	302.86	362.38	281.48	259.27
Interest Expense	-6.56	-9.28	-8.86	-5.07	-3.21	-2.47
Interest & Investment Income	2.33	2.05	1.43	0.61	0.32	2.24
Earnings From Equity Investments	4.8	-5.32	36.08	26.64	14.81	-
Currency Exchange Gain (Loss)	5.32	5.32	-1.93	10.29	-4.31	-1.61
Other Non Operating Income (Expenses)	-1.93	4.18	4.49	1.58	7.87	6.51
EBT Excluding Unusual Items	360.8	300.25	334.07	396.42	296.95	263.94
Gain (Loss) on Sale of Investments	-0.49	-0.49	0.02	0.21	0.98	-0.35
Gain (Loss) on Sale of Assets	-0.15	-0.15	-0.28	-0.21	-0.63	-0.21
Asset Writedown	-	-	-	-	-1.81	-
Pretax Income	360.16	299.61	333.8	396.42	295.49	263.38
Income Tax Expense	68.01	59.4	58.98	75.18	57.72	47.83
Net Income	292.15	240.21	274.83	321.24	237.77	215.55
Net Income to Common	292.15	240.21	274.83	321.24	237.77	215.55
Net Income Growth	22.36%	-12.60%	-14.45%	35.10%	10.31%	14.19%
Shares Outstanding (Basic)	27	27	27	27	27	27
Shares Outstanding (Diluted)	27	27	27	27	27	27
Shares Change (YoY)	-0.04%	-	-0.01%	-0.00%	-0.01%	12.85%
EPS (Basic)	10.77	8.86	10.14	11.85	8.77	7.95
EPS (Diluted)	10.77	8.85	10.13	11.84	8.76	7.94
EPS Growth	22.23%	-12.64%	-14.44%	35.16%	10.33%	1.15%
Free Cash Flow	338.52	287.83	323.23	-306.79	274.83	-52.55
Free Cash Flow Per Share	12.48	10.61	11.91	-11.31	10.13	-1.94
Dividend Per Share	-	5.000	5.000	5.000	4.000	3.500
Dividend Growth	-	-	-	25.00%	14.29%	16.67%
Gross Margin	35.65%	35.95%	35.05%	35.64%	35.91%	37.78%
Operating Margin	16.74%	15.06%	16.48%	18.77%	19.13%	19.77%
Profit Margin	13.71%	11.93%	14.96%	16.64%	16.16%	16.44%
Free Cash Flow Margin	15.88%	14.29%	17.59%	-15.89%	18.68%	-4.01%
EBITDA	462.96	402.1	386.21	432.93	347.82	321.89
EBITDA Margin	21.72%	19.97%	21.02%	22.43%	23.64%	24.55%
D&A For EBITDA	106.13	98.8	83.35	70.56	66.34	62.62
EBIT	356.82	303.3	302.86	362.38	281.48	259.27
EBIT Margin	16.74%	15.06%	16.48%	18.77%	19.13%	19.77%
Effective Tax Rate	18.88%	19.83%	17.67%	18.96%	19.53%	18.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.